B-Aegis Life Sciences & Research Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 30.00 K
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2020
About B-Aegis Life Sciences & Research
B-Aegis Life Sciences & Research Private Limited (BLSRPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 October 2017 (Seven years and four months 8 days old ). Its registered office is in Thiruvananthapuram, Kerala, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 30.00 K , as per Ministry of Corporate Affairs (MCA) records.
Sruthy Surendran and Nandu Surendran serve as directors at the Company.
Company Details
-
Location
Thiruvananthapuram, Kerala, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U73100KL2017PTC050615
-
Company No.
050615
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Oct 2017
-
Date of AGM
13 Oct 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at B-Aegis Life Sciences & Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandu Surendran
|
Managing Director | 05-Oct-2017 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sruthy Surendran
|
Director | 05-Oct-2017 | Current |
Financial Performance of B-Aegis Life Sciences & Research.
Enhance accessibility to B-Aegis Life Sciences & Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B-Aegis Life Sciences & Research?
Unlock access to B-Aegis Life Sciences & Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at B-Aegis Life Sciences & Research?
Unlock and access historical data on people associated with B-Aegis Life Sciences & Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B-Aegis Life Sciences & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B-Aegis Life Sciences & Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.